Collaborative Platform Trials to Fight COVID‐19: Methodological and Regulatory Considerations for a Better Societal Outcome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Collaborative Platform Trials to Fight COVID‐19: Methodological and Regulatory Considerations for a Better Societal Outcome

Published:2021-03-16 Issue:2 Volume:110 Page:311-320
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Collignon Olivier¹,Burman Carl‐Fredrik²,Posch Martin³,Schiel Anja⁴

Affiliation:

1. GlaxoSmithKline Stevenage Hertfordshire UK

2. Statistical Innovation, Data Science, and Artificial Intelligence AstraZeneca R&D Gothenburg Sweden

3. Section for Medical Statistics Center for Medical Statistics, Informatics, and Intelligent Systems Medical University of Vienna Vienna Austria

4. Norwegian Medicines Agency Oslo Norway

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2183

Reference47 articles.

1. Coronavirus drugs trials must get bigger and more collaborative. Nature 581(7807) 120 (2020).

2. The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days

3. Against pandemic research exceptionalism

4. Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings

5. Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials.gov

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovative approaches for vaccine trials as a key component of pandemic preparedness – a white paper;Infection;2024-07-17

2. How Much More Efficient Are Adaptive Platform Trials Than Multiple Stand‐Alone Trials? A Comprehensive Simulation Study for Streamlining Drug Development During a Pandemic;Clinical Pharmacology & Therapeutics;2024-03-05

3. Nonconcurrent Controls in Platform Trials: Can We Borrow Their Concurrent Observation Data?;Statistics in Biopharmaceutical Research;2023-10-05

4. Patient and community engagement in clinical platform trials;Open Research Europe;2023-05-03

5. Online error rate control for platform trials;Statistics in Medicine;2023-04-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3